Patent details

Basic Information

Publication number:

EP3305812

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171860935

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF DR5 AGONIST AND ANTI-PD-1 ANTAGONIST AND METHODS OF USE

French Title of Invention:

COMBINAISON D'AGONISTE DR5 ET D'ANTAGONISTE ANTI-PD-1 ET PROCÉDÉS D'UTILISATION

German Title of Invention:

KOMBINATION VON DR5-AGONISTEN UND ANTI-PD1-ANTAGONISTEN UND VERFAHREN ZUR VERWENDUNG

SPC Number:

Dates

Filing date:

12/03/2014

Grant date:

17/06/2020

EP Publication Date:

11/04/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/06/2020

EP B1 Publication Date:

17/06/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/03/2021

Expiration date:

12/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/06/2020

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:

BARNHART, Bryan

Address:

United States (US)

2

Name:

JURE-KUNKEL, Maria N.

Address:

United States (US)

Priority

Priority Number:

201361783184 P

Priority Date:

14/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28;

Publication

European Patent Bulletin

Issue number:

202025

Publication date:

17/06/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages